Athens, Greece — EYEONIX proudly announces a strategic collaboration with INSERM (Institut National de la Santé et de la Recherche Médicale) and Sorbonne University. This groundbreaking partnership brings Artificial Intelligence (AI) to the frontline of trauma emergency medicine, setting a new global standard for life-saving innovation. The internationally recognized research team ‘Cancer, Angiogenesis, Thrombosis and Hemostasis – CaVITE’ (INSERM U938) will develop advanced clinical algorithms for the early diagnosis and management of hemorrhage in severe trauma cases. These algorithms, rooted in decades of expertise and international medical guidelines, will be seamlessly integrated into the EYEONIX Command platform
“This partnership represents a decisive step in bridging scientific research with real-world emergency medicine. By combining INSERM’s unparalleled expertise with EYEONIX’s Command technology, we empower healthcare professionals to act faster and save more lives.”
The new Trauma Logic edition of COMMAND will be deployed on rugged , continuously connected to Command Centers.
This ensures step-by-step clinical decision support for doctors, medics, and first responders, even in the most challenging environments — from the battlefield to disaster zones. Key Benefits of the Collaboration: • Immediate, evidence-based interventions in critical moments • Reduced cognitive fatigue in high-pressure environments • Standardized care delivery, even in extreme or war-zone conditions • Remote specialist support through EYEONIX’s secure platform
The ultimate goal: to significantly increase survival rates in hemorrhagic trauma by ensuring that interventions take place within the “golden minute” — the first minute after injury, when immediate action is vital.
This collaboration places EYEONIX at the forefront of AI-driven medical decision support technologies, reaffirming the company’s commitment to protecting lives, empowering professionals, and transforming emergency healthcare worldwide.
